Spreadsheets have supported life sciences teams for decades. They’re familiar, flexible, and quick to set up. But as labs scale, especially in regulated environments like cell therapy, biobanking, and advanced biologics – what once worked can quietly become a source of risk. Over the years, our team at Pragmatrix has had the opportunity to work alongside CDMOs, CMOs, and biotech organizations navigating this exact transition. A consistent pattern emerges: spreadsheets don’t usually “fail” overnight. They simply stop keeping pace with operational and regulatory realities. Here are five signs your lab may have outgrown spreadsheet-based sample tracking and key considerations for …